GlaxoSmithKline ( GSK) is reportedly in talks to buy a large stake in generic-drug maker Aspen Pharmacare.

According to a report published Wednesday on the Financial Times' Web site, Glaxo may soon buy 10% of South Africa-based Aspen to bolster the U.K. drugmaker's sales in foreign and emerging markets.

The reported negotiations closely follow rumors that Glaxo might be eying Botox maker Allergan ( AGN) as an acquisition.

Glaxo shares were recently up 1.3% to $29.70.

More from Stocks

Tempted by General Electric's Dividend Yield? Grab Yourself a Burger Instead

Tempted by General Electric's Dividend Yield? Grab Yourself a Burger Instead

Has Wall Street Completely Lost Its Mind on General Electric?

Has Wall Street Completely Lost Its Mind on General Electric?

Tesla CEO Elon Musk Is Cracking Under Immense Stress and Investors Should Worry

Tesla CEO Elon Musk Is Cracking Under Immense Stress and Investors Should Worry

10 Questions for PayPal Ahead of Its Big Investor Day

10 Questions for PayPal Ahead of Its Big Investor Day

Trump Tariff Threat, Deutsche Bank, Elon Musk and Apple - 5 Things You Must Know

Trump Tariff Threat, Deutsche Bank, Elon Musk and Apple - 5 Things You Must Know